Anticancer Drugs Course
This course equips oncology professionals with practical skills to master first-line EGFR TKI treatments for EGFR-mutant NSCLC. Participants learn to select therapies, handle toxicities effectively, address resistance mechanisms, and communicate confidently with patients for better clinical outcomes and patient care.

4 to 360 hours of flexible workload
certificate valid in your country
What Will I Learn?
Gain practical insights into first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Master drug mechanisms, dosing schedules, toxicity management, resistance patterns, second-line choices, monitoring protocols, and patient communication skills for evidence-based decisions.
Elevify Advantages
Develop Skills
- Select optimal EGFR TKI regimens based on latest trial data.
- Plan resistance assessments with imaging, re-biopsy, and liquid biopsy.
- Develop second-line plans matching resistance to targeted or chemo options.
- Manage EGFR TKI toxicities like rash, diarrhoea, ILD, and cytopenias.
- Counsel patients clearly on treatment goals, side effects, and progression.
Suggested Summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses come with a certificate?
Are the courses free?
What is the course duration?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an online course and how does it work?
PDF Course